SNS Financial Group, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1557485 MINNEAPOLIS, MN

Position in VRTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$301,515

New position

Shares Held

607

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,234

of 1,735 holders

Holding Since

Jun 2026

1 quarter on record

Healthcare · as of Jun 30, 2026

SNS Financial Group, LLC holds $12,656,075 across 3 Biotechnology names. VRTX ranks #2 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	19,746	$12,312,420
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	607	$301,515
3	ATNM	Actinium Pharmaceuticals, Inc.	43,000	$42,140

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$301,515	607	—	Shares	Sole	2026-08-11
No filing history on record for this holder in this stock.